恶唑啉|Oxazolines-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

恶唑啉是一种含氧原子和氮原子的五元杂环化合物。它可能最早合成于1884年，但直到5年后，西格蒙·加布里埃尔才正确地指定了这种结构。它与Hantzsch–Widman命名法一致，是一族杂环化合物的一部分，在饱和度方面它存在于噁唑和噁唑烷之间。

按化学元素: B^x; C^x; N^x; O^x; F^x; Si^x; P^x; S^x; Cl^x; Br^x; I^x

母核：

官能团： 酯 (2) 芳基 (7) 酰胺 (1)

按纯度： 99+% 99% 98+% 98% 97+% 97% 96+% 96% 95+% 95% 93% 90+% 90%

按分子量： 0-100 100-200 200-300 300-400 400-500 500-600

按化学元素： CINO CNOSSi CNOP CClFNO CINOS CBrNO CFINO CNOSi CClNOS COS CNO CNOS CNOSe CFNOS CBrKNO CClFNOS CBrNOS CBrClNO CClNO CBrFNO CBrNOSe CFNO CFNOSe CBNO 更多

(S)-4-Benzyl-2-(pyridin-2-yl)-4,5-dihydrooxazole (S)-4-苄基-2-(吡啶-2-基)-4,5-二氢恶唑: BJS0337799108915-08-898%; ￥1741.001g

2,6-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine 2,6-二[(4S)-4-叔丁基-2-噁唑啉基基]吡啶: BJS0606776118949-63-697% 99%ee; ￥3851.005g

(3aR,3'aR,8aS,8'aS)-2,2'-(1-Methylethylidene)bis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole [(3AR,3'AR,8AS,8'AS)-2,2'-异丙叉双[3A,8A-二氢-8H-茚并[1,2-D]恶唑]]: BJS8916842189623-45-898% 99%ee; ￥221.00100mg

(S)-4-(tert-Butyl)-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole 2-[(4S)-4-叔丁基-4,5-二氢-2-恶唑基]-5-三氟甲基吡啶: BJS32038711416819-91-498% 99%ee; ￥187.00100mg

Bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)methane 2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-茚苯[1,2-D]并恶唑]: BJS1490900180186-94-198%; ￥71.00100mg

1,3-Bis((R)-4-isopropyl-4,5-dihydrooxazol-2-yl)benzene 1,3-双((R)-4-异丙基-4,5-二氢恶唑-2-基)苯: BJS06838261086138-48-898% 99%ee; ￥4379.001g

(S)-4-(tert-Butyl)-2-(quinolin-2-yl)-4,5-dihydrooxazole (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑: BJS2378364226387-12-897% 99%ee; ￥2627.001g

(3aR,3a'R,8aS,8a'S)-2,2'-(Ethane-1,1-diyl)bis(3a,8a-dihydro-8H-indeno[1,2-d]oxazole) (3aR,3'aR,8aS,8'aS)-2,2'-亚乙基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑]: BJS3515241950596-31-397% 99%ee; ￥1653.00250mg

(S)-4-Benzyl-2-(5-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole (S)-4-苄基-2-(5-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑: BJS18055461803416-29-697% 99%ee; ￥924.00250mg

(R)-4-Isopropyl-2-(4-(trifluoromethyl)pyridin-2-yl)-4,5-dihydrooxazole (R)-4-异丙基-2-(4-(三氟甲基)吡啶-2-基)-4,5-二氢噁唑: BJS26560812828432-06-897% 99%ee; ￥968.00100mg

(R)-2-(6-Benzhydrylpyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole (R)-2-(6-二苯甲基吡啶-2-基)-4-异丙基-4,5-二氢恶唑: BJS30082192757083-49-997% 99%ee; ￥1590.0050mg

(4R,4'R)-2,2'-(Propane-2,2-diyl)bis(4-methyl-4,5-dihydrooxazole) (4R,4'R)-2,2'-(丙烷-2,2-二基)双(4-甲基-4,5-二氢恶唑): BJS7632038280755-86-497%; ￥277.00100mg

(4R,4'R)-2,2'-(Pentane-3,3-diyl)bis(4-methyl-4,5-dihydrooxazole) (4R,4'R)-2,2'-(戊烷-3,3-二基)双(4-甲基-4,5-二氢恶唑): BJS72639032828432-10-497%; ￥2161.00100mg

(S)-4-(tert-Butyl)-2-(2-((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)-1,3-diphenylpropan-2-yl)-4,5-dihydrooxazole (S)-4-(叔丁基)-2-(2-((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)-1,3-二苯基丙烷-2-基)-4,5-二氢恶唑: BJS32951902634687-78-697%; ￥1964.00100mg

(R)-4-(tert-Butyl)-2-(2-(pyridin-2-yl)propan-2-yl)-4,5-dihydrooxazole (R)-4-(叔丁基)-2-(2-(吡啶-2-基)丙-2-基)-4,5-二氢恶唑: BJS39614442757083-51-397%; ￥806.00100mg

(R)-2-(5-Bromopyridin-2-yl)-4-isopropyl-4,5-dihydrooxazole (R)-2-(5-溴吡啶-2-基)-4-异丙基-4,5-二氢恶唑: BJS36438832757083-30-897% 99%ee; ￥6094.001g

(R)-2-(5-Bromopyridin-2-yl)-4-phenyl-4,5-dihydrooxazole (R)-2-(5-溴吡啶-2-基)-4-苯基-4,5-二氢恶唑: BJS94961052757083-31-997% 99%ee; ￥1964.00100mg

(R)-2-(6-Benzhydrylpyridin-2-yl)-4-ethyl-4,5-dihydrooxazole (R)-2-(6-二苯甲基吡啶-2-基)-4-乙基-4,5-二氢恶唑: BJS07971512828438-67-997%; ￥1869.00100mg

(R)-2-(6-Benzhydrylpyridin-2-yl)-4-methyl-4,5-dihydrooxazole (R)-2-(6-二苯甲基吡啶-2-基)-4-甲基-4,5-二氢恶唑: BJS82815272828438-69-197%; ￥1869.00100mg

(R)-2-(Benzo[b]thiophen-2-yl)-4-methyl-4,5-dihydrooxazole (R)-2-(苯并[b]噻吩-2-基)-4-甲基-4,5-二氢恶唑: BJS97695322828439-75-298%; ￥956.00100mg

1 2 3 4 5 6 7 8 9 ... 15